Which aspect does NOT fall under adulteration?

The concept of adulteration primarily refers to the quality and purity of drugs and substances involved in pharmacy practice. It specifically pertains to the condition of drugs being compromised due to factors such as contamination or the presence of harmful substances.

The presence of harmful additives and drugs packaged in unsanitary conditions clearly fall under adulteration, as they directly affect the safety and efficacy of the medication. Furthermore, when a drug is not compliant with manufacturing standards, it also constitutes adulteration, since these standards are in place to ensure that products are safe for consumer use.

Misleading consumer information, however, does not directly relate to the physical properties or quality of the drug. While it may have implications for consumer awareness and can be an ethical issue in practice, it does not constitute adulteration as defined in pharmaceutical law. Adulteration focuses on the integrity of the drug itself rather than how it is represented or marketed to consumers. Hence, this aspect does not fall under the definition of adulteration.